Trial intelligence / Profile preview

Effect of sugammadex on respiratory compliance in ventilated children

jRCTs041220060Completed

Start
Sep 2022
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label, single-arm trial of Sugammadex. Started Sep 2022; status: completed.

02

Drugs

Sugammadex

Beyond the preview

Go deeper on jRCTs041220060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041220060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call